U.S. benchmarks have pared early losses ahead of the bell, though still lingering in negative territory.
U.S. benchmarks finished yesterday on steady strength after whipsawing to start the intraday session.
An exuberant start to the week closed on a soft note yesterday after headlines reminded market participants the White House is mulling over sanctions on China for how they handled the Covid-19 outbreak.
Risk-assets are surging on the heels of the long Memorial Day weekend and signs that the worst of Covid-19 is behind us.
U.S equity benchmarks were paring overnight losses ahead of the bell and long Memorial Day weekend.
U.S benchmarks are firm this morning, gaining ground across the board; all eyes are on the Federal Reserve.
U.S. Jobless Claims, New Home Sales and KC Fed Manufacturing are released today.
U.S benchmarks once again constructively held technical support though yesterday’s session; news that Gilead’s Covid-19 drug shows moved markets higher.
U.S benchmarks finished Friday on a very ugly note, settling below the December 2018 low, and kicked off this week by gapping lower. The S&P traded to the lowest level since the week after President Trump’s 2016 election. Hopes of massive fiscal stimulus are stalling in the Senate.
S&P responded to the first test of the December 2018 low by gaining as much as 13%. Yesterday, the S&P took out that low, but did not close below it. It has become evident since Monday that the panic is still playing out and we voiced here yesterday that we expected the market to break below 2300.